| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Graduate Institute of Cell and Molecular Biology and 2 Graduate Institute of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan; 3 Department of Dermatology, Taipei Municipal Wan-Fang Hospital-Affiliated with Taipei Medical University, Taipei, Taiwan; 4 Department of Life Science, National Chung Cheng University, Chia-Yi, Taiwan; 5 Department of Biochemistry, Taipei Medical University, Taipei, Taiwan; and 6 Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan
The Notch signal pathway plays important roles in proliferation, apoptosis, and differentiation. Abnormalities in Notch signaling are linked to many human diseases. After ligand binding, Notch signaling is activated through the cleavage of Notch receptors to release and translocate the Notch intracellular domain into the nucleus. The Notch1 receptor intracellular domain (N1IC), the activated form of the Notch1 receptor, can modulate downstream target genes via C promoter-binding factor 1dependent and -independent pathways. To further dissect the Notch1 signaling pathway, we screened the N1IC-associated proteins using a yeast two-hybrid system and identified nuclear ßII-tubulin as a candidate for the N1IC-associated proteins. It was suggested that the presence of ßII-tubulin in nuclei might be correlated with the cancerous state of cells. However, the function of ßII-tubulin locating in the nucleus still is unknown. Herein, we show that the complex of
- and ßII-tubulin is associated with N1IC in cancer cells by a coimmunoprecipitation analysis. The ankyrin domain of the Notch1 receptor alone was sufficient to associate with ßII-tubulin. Furthermore,
- and ßII-tubulin were localized in the nucleus and formed a complex with N1IC. Treatment with Taxol increased the amounts of nuclear
- and ßII-tubulin in K562 and HeLa cells and promoted the C promoter-binding factor 1dependent transactivation activity of N1IC. We also show that nuclear ßII-tubulin was bound on the C promoter-binding factor 1 response elements via the association with N1IC. These results suggest that nuclear ßII-tubulin can modulate Notch signaling through interaction with N1IC in cancer cells.
This article has been cited by other articles:
![]() |
Y.-F. Lin, W.-P. Tsai, H.-G. Liu, and P.-H. Liang Intracellular {beta}-Tubulin/Chaperonin Containing TCP1-{beta} Complex Serves as a Novel Chemotherapeutic Target against Drug-Resistant Tumors Cancer Res., September 1, 2009; 69(17): 6879 - 6888. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lee, C. Chae, and M. M. Wang p150/Glued Modifies Nuclear Estrogen Receptor Function Mol. Endocrinol., May 1, 2009; 23(5): 620 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akoumianaki, D. Kardassis, H. Polioudaki, S. D. Georgatos, and P. A. Theodoropoulos Nucleocytoplasmic shuttling of soluble tubulin in mammalian cells J. Cell Sci., April 15, 2009; 122(8): 1111 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Hsu, R.-H. Hsieh, Y.-H. W. Lee, C.-H. Chao, K.-J. Wu, M.-J. Tseng, and T.-S. Yeh The Activated Notch1 Receptor Cooperates with {alpha}-Enolase and MBP-1 in Modulating c-myc Activity Mol. Cell. Biol., August 1, 2008; 28(15): 4829 - 4842. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-R. Liao, R.-H. Hsieh, K.-W. Hsu, M.-Z. Wu, M.-J. Tseng, R.-T. Mai, Y.-H. Wu Lee, and T.-S. Yeh The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1 Carcinogenesis, September 1, 2007; 28(9): 1867 - 1876. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |